Yan Ding

2.1k total citations
51 papers, 1.6k citations indexed

About

Yan Ding is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Endocrine and Autonomic Systems. According to data from OpenAlex, Yan Ding has authored 51 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 16 papers in Pulmonary and Respiratory Medicine and 10 papers in Endocrine and Autonomic Systems. Recurrent topics in Yan Ding's work include Renal cell carcinoma treatment (7 papers), Neuroscience of respiration and sleep (7 papers) and Ferroptosis and cancer prognosis (5 papers). Yan Ding is often cited by papers focused on Renal cell carcinoma treatment (7 papers), Neuroscience of respiration and sleep (7 papers) and Ferroptosis and cancer prognosis (5 papers). Yan Ding collaborates with scholars based in China, United States and Singapore. Yan Ding's co-authors include Dan Huang, Bin Tean Teh, Chao-Nan Qian, Kristin VandenBeldt, David Petillo, Kyle A. Furge, P. Andrew Futreal, Richard J. Kahnoski, Ming Zhou and Brian I. Rini and has published in prestigious journals such as Nature Communications, Cancer Research and Oncogene.

In The Last Decade

Yan Ding

49 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Ding China 20 963 437 340 319 206 51 1.6k
Xuesong Ouyang United States 18 1.3k 1.3× 508 1.2× 333 1.0× 419 1.3× 147 0.7× 28 1.8k
Daniele Avanzato Italy 15 996 1.0× 236 0.5× 338 1.0× 465 1.5× 160 0.8× 18 1.8k
Xiaobing Deng United States 24 1.2k 1.3× 222 0.5× 300 0.9× 436 1.4× 195 0.9× 39 1.8k
Qingbin Kong China 15 1.0k 1.1× 217 0.5× 398 1.2× 364 1.1× 191 0.9× 17 1.7k
Honyin Chiu United States 6 1.3k 1.3× 281 0.6× 318 0.9× 400 1.3× 308 1.5× 7 2.0k
Chia‐Lang Hsu Taiwan 25 1.1k 1.1× 312 0.7× 480 1.4× 364 1.1× 387 1.9× 118 1.8k
Sushant K. Kachhap United States 21 1.4k 1.5× 305 0.7× 442 1.3× 405 1.3× 98 0.5× 48 1.9k
Xiangjin Zheng China 21 1.2k 1.2× 252 0.6× 609 1.8× 257 0.8× 235 1.1× 27 1.7k

Countries citing papers authored by Yan Ding

Since Specialization
Citations

This map shows the geographic impact of Yan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Ding more than expected).

Fields of papers citing papers by Yan Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Ding. The network helps show where Yan Ding may publish in the future.

Co-authorship network of co-authors of Yan Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Ding. A scholar is included among the top collaborators of Yan Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Ding. Yan Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Cheng, Jiayi Wang, Zhijun Wu, et al.. (2025). Timing of Adjuvant Chemotherapy After Gastrectomy in Patients With Stage II to III Gastric Cancer: A Target Trial Emulation Study. JCO Precision Oncology. 9(9). e2500664–e2500664.
2.
Ding, Yan, Lei Zhao, Lijun Zhang, et al.. (2025). Identification and Validation of Cuproptosis-Related Signature to Predict Prognosis and Characterize Tumor Immune Infiltration in Kidney Clear Cell Carcinoma. Indian Journal of Surgical Oncology. 16(5). 1054–1064. 1 indexed citations
3.
Wen, Q. G., Yan Ding, Sheng Luo, et al.. (2025). MDN1 variants cause susceptibility to epilepsy. PubMed. 7(1). 17–17. 1 indexed citations
4.
Ding, Yan, et al.. (2024). Phosphorylation of INF2 by AMPK promotes mitochondrial fission and oncogenic function in endometrial cancer. Cell Death and Disease. 15(1). 65–65. 9 indexed citations
5.
Guo, Jing, Kai Peng, Qiong‐Xiang Zhai, et al.. (2024). SLC2A1 variants cause late-onset epilepsy and the genetic-dependent stage feature. PubMed. 6(1). 38–38. 4 indexed citations
6.
Gao, Kun, Qing Shi, Ye Gu, et al.. (2022). SPOP mutations promote tumor immune escape in endometrial cancer via the IRF1–PD-L1 axis. Cell Death and Differentiation. 30(2). 475–487. 28 indexed citations
7.
Li, Chunbo, Yan Ding, Xuyin Zhang, & Keqin Hua. (2022). Integrated in silico analysis of LRP2 mutations to immunotherapy efficacy in pan-cancer cohort. Discover Oncology. 13(1). 65–65. 6 indexed citations
8.
Cui, Liyuan, Xu Feng, Zhuxuan Jiang, et al.. (2021). Melatonin regulates proliferation and apoptosis of endometrial stromal cells via MT1. Acta Biochimica et Biophysica Sinica. 53(10). 1333–1341. 12 indexed citations
9.
Ding, Yan, et al.. (2020). Scheuermann’s Disease as a Risk Factor for Lumbar Disc Herniation Recurrence. Journal of College of Physicians And Surgeons Pakistan. 30(6). 584–589. 2 indexed citations
10.
Qiu, Junjun, Yingying Lin, Xiaoyan Tang, et al.. (2020). Extracellular vesicle-mediated transfer of the lncRNA-TC0101441 promotes endometriosis migration/invasion. Experimental Cell Research. 388(1). 111815–111815. 32 indexed citations
11.
Sun, Xiaohan, Yan Ding, Meixiao Zhan, et al.. (2019). Usp7 regulates Hippo pathway through deubiquitinating the transcriptional coactivator Yorkie. Nature Communications. 10(1). 411–411. 72 indexed citations
12.
Ding, Yan, Xuefei Hou, Li Chen, et al.. (2015). Heme oxygenase-1 dependant pathway contributes to protection by tetramethylpyrazine against chronic hypoxic injury on medulla oblongata in rats. Journal of the Neurological Sciences. 361. 101–111. 7 indexed citations
13.
Ding, Yan, et al.. (2013). Proteins related to early changes in carcinogenesis of hepatic oval cells after treatment with methylnitronitrosoguanidine. Experimental and Toxicologic Pathology. 66(2-3). 139–146. 3 indexed citations
14.
Ding, Yan, Dan Huang, Zhongfa Zhang, et al.. (2011). Combined Gene Expression Profiling and RNAi Screening in Clear Cell Renal Cell Carcinoma Identify PLK1 and Other Therapeutic Kinase Targets. Cancer Research. 71(15). 5225–5234. 31 indexed citations
15.
Huang, Dan, Yan Ding, Ming Zhou, et al.. (2010). Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma. Cancer Research. 70(3). 1063–1071. 330 indexed citations
16.
Huang, Dan, Yan Ding, Yan Li, et al.. (2010). Sunitinib Acts Primarily on Tumor Endothelium rather than Tumor Cells to Inhibit the Growth of Renal Cell Carcinoma. Cancer Research. 70(3). 1053–1062. 188 indexed citations
17.
Wang, Qing, Juan Li, Jingli Gu, et al.. (2009). Potentiation of (−)-epigallocatechin-3-gallate-induced apoptosis by bortezomib in multiple myeloma cells. Acta Biochimica et Biophysica Sinica. 41(12). 1018–1026. 18 indexed citations
18.
Ding, Yan, Elissa A. Boguslawski, Bree D. Berghuis, et al.. (2008). Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma. Molecular Cancer Therapeutics. 7(3). 648–658. 29 indexed citations
19.
Huang, Dan, Yan Ding, Chao‐Nan Qian, et al.. (2008). Inhibition of MAPK Kinase Signaling Pathways Suppressed Renal Cell Carcinoma Growth and Angiogenesis In vivo. Cancer Research. 68(1). 81–88. 179 indexed citations
20.
Mazzuca, Steven A., K D Brandt, Barry P. Katz, et al.. (2006). Risk factors for early radiographic changes of tibiofemoral osteoarthritis. Annals of the Rheumatic Diseases. 66(3). 394–399. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuesong Ouyang Breakdown of academic impact, for papers by Daniele Avanzato Breakdown of academic impact, for papers by Xiaobing Deng Breakdown of academic impact, for papers by Qingbin Kong Breakdown of academic impact, for papers by Honyin Chiu Breakdown of academic impact, for papers by Chia‐Lang Hsu Breakdown of academic impact, for papers by Sushant K. Kachhap Breakdown of academic impact, for papers by Xiangjin Zheng
Rankless by CCL
2026